Skip to main content
FinSpry Logo
FinSpry
RPRX logo
RPRX
(NASDAQ)
Royalty Pharma plc
$47.32-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Royalty Pharma (RPRX) Stock Price & Financial Analysis

Royalty Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$47.28 - $48.39
52-Week High$48.75
52-Week Low$29.66
Open$47.98
Volume2.77M
Average Volume (3M)2.72M
Market Cap27.18B
Shares Outstanding559.61M
P/E Ratio (TTM)35.20
Forward P/E39.22
Price to Sales (P/S)11.41
Price to Book (P/B)4.19
EV/EBITDA21.70
Revenue (TTM)2.38B
Net Income (TTM)770.95M
EPS (TTM)$1.38
Profit Margin32.42%
Operating Margin65.58%
Return on Equity (ROE)11.90%
Debt to Equity1.38
50-Day MA$44.80
200-Day MA$39.16
52-Week Change55.57%
Annual Dividend$0.90
Dividend Yield1.85%
Payout Ratio64.97%
Last Dividend Ex-DateFeb 20, 2026

Frequently Asked Questions About Royalty Pharma

What is the current stock price for RPRX?

As of the latest trading session, RPRX stock trades at $47.32. The 52-week range is $29.66–$48.75, with a day range of $47.27–$48.39.

What is the P/E ratio for RPRX?

Royalty Pharma's trailing P/E ratio is 35.2, meaning investors pay $35.2 for every $1 of annual earnings. The forward P/E is 39.2, reflecting analyst expectations for future earnings. Royalty Pharma operates in the Healthcare sector.

Does RPRX pay dividends?

Yes, Royalty Pharma pays a 1.85% annual dividend yield ($0.90 per share). The payout ratio is 65.0%. The last ex-dividend date was 2026-02-20.

What do analysts recommend for RPRX?

Based on 1 analyst, the consensus for RPRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RPRX?

Royalty Pharma's market capitalization is $26.48B, classifying it as a large-cap company. Royalty Pharma operates in the Healthcare sector within the Biotechnology industry.